Testing effectiveness (Phase 2)Study completedNCT02646189
What this trial is testing
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 12
Showing 20 of 0 results